Πέμπτη 1 Φεβρουαρίου 2018

Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis

To explore potential design for pharmacogenomics trials in sepsis, we investigate the interaction between pharmacogenomic biomarkers and response to drotrecogin alfa (activated) (DrotAA). This trial was desig...

from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2nrlqbS

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις